# FREEZE-AFIB Post-Market Study

> **NCT05089877** · — · COMPLETED · sponsor: **AtriCure, Inc.** · enrollment: 39 (actual)

## Conditions studied

- Atrial Fibrillation
- Atrial Flutter

## Interventions

- **DEVICE:** Surgical Ablation

## Key facts

- **NCT ID:** NCT05089877
- **Lead sponsor:** AtriCure, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-29
- **Primary completion:** 2023-03-31
- **Final completion:** 2023-12-31
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2025-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05089877

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05089877, "FREEZE-AFIB Post-Market Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05089877. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*